| BUSINESS INFORMATION | Co. launched a dedicated business--called custom synthesis and service--in October 2001. |
| PRODUCER'S COUNTRY | manufacturing sites in France, Switzerland, and Germany pursued custom business independently; under the new organization, marketing for all sites will be consolidated, allowing third-party projects to be directed to the most suitable facility |
| SALES VALUE | Co. reports 50% growth in custom synthesis sales over the past year. "We are, despite the discussion in the industry about overcapacity and fewer new drug launches, optimistic about the business," he says. Co.'s recent sales growth is taking Co. a long way toward his goal, set out last year, of more than doubling the business' annual sales to $100 million over the next three to four years. |
| UPDATE | 12.02 |
| COMPANY | Merck KGaA |
| CUSTOMER |
- AstraZeneca - Solvay |
| LITERATURE REF. | This data is not available for free |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |